Introduction
============

One fundamental biology question is how animals grow to the right size. The mechanism by which animals orchestrate the growth of their individual cells, tissues and organs is a long-standing mystery. Hormones and nutrients play certain roles in the regulation of tissue growth, but organ size is modulated in intact animals by genetic signaling networks. During the last decade, the Hippo pathway, which was first shown to regulate cell proliferation and apoptosis during development and regeneration, has been recognized as one of the most important mechanisms of size control in animals. Many of the key components in the Hippo pathway and its basic signal transduction steps were originally discovered from genetic screens in the fruit fly,*Drosophila melanogaster*, and this pathway was later found to be the major size control mechanism that is evolutionarily and functionally conserved in vertebrates [@B1]-[@B6].

In *Drosophila*, key components of the Hippo pathway fall into three main classes: the Hippo kinase cassette, downstream transcriptional regulators, and upstream inputs (Fig. [S1](#SM1){ref-type="supplementary-material"}).

\(i\) The Hippo kinase cassette. Hippo, Salvador (Sav), Warts, and Mob-as-tumor-suppressor (Mats), which form the core of the Hippo pathway, were discovered in tumor suppressor genetic screens in *Drosophila*[@B7]-[@B17]. Both Hippo and Warts are Ser/Thr kinases, and Sav and Mats are the adaptor proteins of Hippo and Warts, respectively. Importantly, Hippo-Sav phosphorylates and activates Warts-Mats, and the four proteins form a complex kinase cascade.

\(ii\) The Hippo downstream transcriptional regulators. The transcriptional coactivator Yorkie is the most critical substrate and downstream effector of the Hippo pathway [@B2], [@B18]-[@B24]. Via direct protein-protein interaction, Yorkie is phosphorylated at three Ser residues (Ser168 is the most critical one in *Drosophila*) by Warts and is thus inactivated. Upon phosphorylation, Yorkie is relocated to the cytoplasm. When the Hippo pathway is inactivated, *Yorkie* functions as an oncogene in the nucleus by acting as a transcriptional coactivator. The Hippo pathway negatively regulates Yorkie activity by preventing its accumulation within the nucleus. Once in the nucleus, Yorkie binds and activates several transcription factors, including Scalloped (Sd), Homothorax (Hth), Teashirt, and Mothers against DPP, to induce gene expression. For example, Yorkie-Sd induces expression of *cyclin E*(*cycE*) and *inhibitor of apoptosis protein 1* (*diap1*) to promote cell proliferation and to inhibit apoptosis, respectively [@B20], [@B21]. In addition, the microRNA*bantam*, the oncogene *Myc*, and several Hippo upstream regulators are potent target molecules of Yorkie.

\(iii\) The Hippo upstream inputs. Many of the Hippo upstream regulators control cellular processes such as apical-basal cell polarity, planar cell polarity, and cell-cell adhesion [@B1], [@B2], [@B5]. Fat is a large transmembrane protein that is critical for maintaining both planar cell polarity and the Hippo pathway. Dachsous (Ds) is a ligand for Fat [@B25]-[@B27]. Crumbs (Crb) is an apical transmembrane protein that organizes both apical-basal polarity and the Hippo signaling [@B28]-[@B30]. Expanded (Ex), Merlin (Mer), and Kibra colocalize at the apical domains of polarized epithelial cells, forming the Ex-Mer-Kibra complex. The three proteins physically interact with each other, and are partially redundant in activating the Hippo kinase cassette [@B31]-[@B34]. Crb binds to Ex, affecting Ex stability and localization and thus the Hippo pathway, but Ds-Fat signaling is genetically distinguishable from Hippo regulation by the Ex-Mer-Kibra complex [@B2]. Two other polarity complexes, the Scribble (Scrib) complex (Scrib; Discs large, Dlg; Lethal giant larva, Lgl) and the Par complex (Par3; Par6; atypical Protein kinase C, aPKC), are also involved in the Hippo pathway. The Lgl complex regulates apical-basal polarity by modulating the components of the Crb complex and the aPKC complex. In general, the Lgl complex activates the Hippo pathway, while the aPKC complex antagonizes the Lgl complex [@B35]-[@B37].

In mammals, a conserved Hippo kinase cascade and*Yorkie* function exist. However, the Hippo upstream inputs have additional complexity and, in some cases, are divergent from *Drosophila*. Mechanotransduction and G-protein-coupled receptor (GPCR) signaling were identified as additional Hippo upstream regulators. Importantly, actin cytoskeleton and cellular tension appear to be the master mediators that integrate and transmit upstream signals to the Hippo kinase cascade and *Yorkie*function [@B3]-[@B6]. The Hippo pathway is largely conserved in *Caenorhabditis elegans* [@B38]. Moreover, key components in the Hippo pathway are found in the cnidarians, a very basal group of metazoans, and even in the unicellular ancestors of animals, the amoeboid holozoans, showing that the hippo pathway evolved well before the origin of Metazoa [@B39], [@B40]. Moreover, a distinct interaction interface between Yorkie and Sd became structurally fixed in the eumetazoan common ancestor [@B41], showing that the ancient evolutionary history of the Hippo pathway as a key developmental mechanism in all animals.

Apart from *Drosophila*, the domesticated silkworm, *Bombyx mori*, is another model insect for general biology [@B42]. In this study, we found that the Hippo pathway is evolutionarily conserved in the silkworm. Temporal and spatial expression patterns suggest that all of the Hippo pathway genes coordinately regulate organ growth and growth of the whole body. Moreover, *Yorkie* facilitates organ growth and accelerates metamorphosis. This study provides potential for promoting growth of the silk gland and thus silk yield by genetic modification of *Yorkie* in the silk gland, and suggests that the evolutionarily conserved Hippo pathway might play a crucial role in size control in the silkworm.

Materials and Methods
=====================

Animals
-------

*Bombyx*larvae (*P50*strain) were raised and provided by the Sericultural Research Institute, Chinese Academy of Agricultural Sciences. The silkworms were reared with fresh mulberry leaves in the laboratory using previously described conditions [@B43].

Gene identification
-------------------

Gene identification was performed according to a method we reported previously [@B43]. We mainly used SilkDB, <http://silkworm.genomics.org.cn>/, to search for potential Hippo pathway genes. First, we used the sequences of 18 key proteins in the *Drosophila* Hippo pathway to search against the GLEAN gene collection to identify Hippo pathway genes in the silkworm by local BLASTP, with an E-value threshold of 10^-6^. KAIKObase, <http://sgp.dna.affrc.go.jp/KAIKObase>/, was used for obtaining some full length cDNA sequences. The identified putative Hippo pathway genes were validated by searching the NCBI protein database with the putative Hippo pathway gene sequences as queries. Furthermore, each potential Hippo pathway gene was analyzed using Pfam to identify its domains. Finally, the identified silkworm Hippo pathway genes were used to search both SilkDB and KAIKObase to avoid missing any genes.

Phylogenetic analysis
---------------------

At least one representative genome was selected for most orders of sequenced arthropod species, whose genomic information is available from NCBI, <http://www.ncbi.nlm.nih.gov> or predicted form the genome databases. The arthprod species (and Yorkie sequences) used are *Ixodes scapularis*(XP_002399565.1)*, Stegodyphus mimosarum*(KFM74842.1)*, Strigamia maritima* (SMAR013599-PA*,*predicted)*, Daphnia pulex*(EFX70433.1)*, Timema cristinae*(Tcri27797*,*predicted)*, Zootermopsis nevadensis*(KDR09902.1)*, Drosophila melanogaster*(XP_001976544.1)*, Tribolium castaneum*(XP_970492.1)*, Apis mellifera*(XP_391844.3)*, Pediculus humanus humanus*(XP_002433100.1)*, Acyrthosiphon pisum*(XP_001948042.1)*, Plutella xylostella*(XP_011558709.1)*, Amyelois transitella*(XP_013194179.1)*, Papilio polytes*(XP_013134895.1)*, Helicoverpa armigera*(ALO18798.1)*,*and*Bombyx mori*(NP_001116819.1). The protein sequence of *Drosophila* Yorkie was used as the seed to search for putative orthologs across the whole genome by reciprocal BLAST. Multiple alignments of Yorkie proteins were then performed using MUSCLE [@B44], and the two WW domains of these alignments were extracted using Gblocks [@B45]. Maximum-likelihood phylogenies were calculated using PhyML [@B46] with the JTT model for 100 replicates.

Microarray analysis
-------------------

We initially used the genome-wide microarray data of the silkworm, which was previously performed in 2007 [@B47], to profile the expression patterns of Hippo pathway genes in multiple larval tissues and during metamorphosis. From the public SilkDB, we downloaded the normalized microarray data for genome-wide gene expression in a number of tissues on day 3 of the fifth larval instar (L5-3) and at 19 sequential time points during metamorphosis. The expression pattern of the Hippo pathway genes was estimated from intensity values. If the normalized intensity of a Hippo pathway gene value exceeded 0, the gene was considered to be expressed [@B47].

Quantitative real-time PCR
--------------------------

Total RNA was extracted for quantitative real-time PCR (qPCR) analysis as previously described in detail [@B43]. qPCR was carried out in a 20 μl reaction solution, which contains 10 μl of SYBR Green real-time PCR Master Mix (Bio-Rad, USA), 5 μl of first strand cDNA template, and 0.5 mM of each primer. The iQ5 Real-Time PCR Detection System (Bio-Rad, USA) was employed. Rp49 was chosen as a reference gene for qPCR analysis. Table [S1](#SM1){ref-type="supplementary-material"} shows the primers used in this paper.

RNA interference of *Yorkie* in *Bombyx larvae*
-----------------------------------------------

*EGFP* (full length) and *Yorkie* (101-500 bp) dsRNA was generated using the T7 RiboMAX™ Express RNAi system (Promega, USA). At the initiation of the early wandering stage (IW), each larva was injected with either *EGFP* dsRNA (30 μg) or *Yorkie* dsRNA (30 μg). Twenty-four h after RNA interference (RNAi) treatment, the larvae were sacrificed [@B43]. Ovary/testis, posterior silk gland (PSG), wing disc, and fat body tissues were collected for further analysis. For the RNAi experiments, 30 animals were used for each group, and 3 biological replicates were conducted.

Baculovirus-mediated overexpression of *Yorkie*and *Yorkie^CA^* in *Bombyx larvae*
----------------------------------------------------------------------------------

The *Bombyx*Yorkie Ser97 corresponds to the *Drosophila* Yorkie Ser168. According to the original discovery in *Drosophila* [@B19], Ser97 of the *Bombyx Yorkie*was mutated to Ala97 to generate the constitutive-active form of *Yorkie* (*Yorkie^CA^*) by using PCR-mediated site-directed mutagenesis. The V5 tag (encoding the amino acid sequence of GKPIPNPLLGLDST) sequence was fused in the 5\' end of *Yorkie* or *Yorkie^CA^* to generate *V5-Yorkie* or *V5-Yorkie^CA^*. *V5-Yorkie* or *V5-Yorkie^CA^* was cloned into the EcoRI-NotI sites of the pFastBac-HTa (Invitrogen) plasmid, and*DsRed2* (a type of red fluorescent protein, *RFP*) was used as a control.

We have previously employed the AcNPV ecdysteroid UDP-glucosyl transferase (*egt*) mutant for gene overexpression in *Bombyx* [@B48], [@B49], but this baculovirus does not produce sufficient *Yorkie*and *Yorkie^CA^* proteins for functional studies. Here, using the homologous recombination technique, we generated an *egt* mutant of *Bombyx mori*nucleopolyhedrosis baculovirus (BmNPV). This virus allows silkworms to survive until pupation and to produce sufficient*Yorkie*and *Yorkie^CA^* proteins. The pFastBac-HTa plasmids of *V5-Yorkie* and *V5-Yorkie^CA^* were then transformed into DH10BacΔEGT bacteria 47 to prepare bacmid DNA according to the protocol of the Bac-to-Bac system. Bm-N cells were transfected with bacmid DNA (1 μg/ml) using Cellfectin II transfection reagent (Invitrogen). After 7 days, P1 virus was collected. The P1 virus was then used to prepare P2 virus after another 3 days. Bm-N cells infected with the P2 virus were collected for silkworm injection experiments on L5-2. One hundred and twenty h after virus treatment, the larvae were sacrificed for analyses. For the overexpression experiments, 30 animals were used for each group, and 3 biological replicates were conducted.

Western blotting and immunohistochemistry
-----------------------------------------

The V5 antibody (1:1000) (Invitrogen, USA) was used to detect the overexpressed *V5-Yorkie* or *V5-Yorkie^CA^* in the PSG by Western blotting as previously described in detail [@B49].

For detecting the overexpressed *V5-Yorkie* or *V5-Yorkie^CA^* by immunohistochemistry, the newly dissected fat body tissues were fixed in 4% paraformaldehyde for 45 min at room temperature. Fat body tissues were blocked in phosphate buffered saline (PBS) containing 5% BSA and 1% Triton-X (PBSBT) for 1 h, and then incubated with the V5 antibody (diluted 1:50) at 4°C overnight. Fat body tissues were washed multiple times for 1 h in PBSBT, and then incubated with a FITC-(green) conjugated secondary antibody (diluted 1:200) for 2 h. DAPI (Sigma) was added to label nuclei. Fat body tissues stained with V5 antibody and DAPI were imaged using an FV10-ASW confocal microscope (Olympus, Japan) at 20×magnification [@B49].

Statistics
----------

Throughout the study, the experimental data were analyzed using Student\'s t-test: \*, p\<0.05; \*\*, p\<0.01; \*\*\*, p\<0.001. Meanwhile, the values are represented as the mean ± standard deviation.

Results
=======

Identification of key genes in the Hippo pathway
------------------------------------------------

Eighteen key proteins in the *Drosophila* Hippo pathway were used in BLASTP queries against the SilkDB and KAIKObase databases. Each potential protein in the *Bombyx* Hippo pathway was validated by searching its known orthologs from the NCBI protein database and further searching its conserved domain(s) with the Pfam program. As a result, a total of 18 putative genes in the Hippo pathway were identified in the silkworm genome. Their encoding proteins fall into three main classes: the Hippo kinase cassette (Hippo, Sav, Warts, and Mats), downstream transcriptional regulators (Yorkie and Sd), and upstream inputs (Ds and Fat; Crb; Ex, Mer, and Kibra; Scrib, Dlg, and Lgl; and Par3, Par6, and aPKC) (Fig. [S1](#SM1){ref-type="supplementary-material"}). As revealed by domain analysis (Fig. [1](#F1){ref-type="fig"}), Hippo is a Ste20 family protein kinase, Sav contains one WW domain, Warts is an NDR family protein kinase, and Mats has a Mob1/phocein domain. Yorkie contains two WW domains, and Sd belongs to the TEA transcriptional enhancer factor superfamily. The transmembrane proteins Ds and Fat contain 22 and at least 10 (the Fat sequence is likely incomplete) cadherin repeats, respectively. The transmembrane protein Crb has multiple epidermal growth factor (EGF)-like domains and Laminin G-like domains. Ex and Mer are similar to each other, containing FERM (4.1 protein, ezrin, radixin, moesin) domains; Kibra has two WW domains, one C2 domain, and one component of oligomeric Golgi complex 7 (COG7) domain. Scrib has multiple leucine-rich repeats; Dlg contains one Guanylate kinase domain and three PDZ domains, and Lgl belongs to the WD40 superfamily. Par3 contains two PDZ domains and one DUF3534 domain; Par6 has one PDZ domain and one PB1 domain, while aPKC is an atypical protein kinase C.

In SilkDB, eight Hippo pathway genes have evidence for mRNA expression with expressed sequence tags (ESTs), which were collected from 36 different cDNA libraries. Based on the EST information, *Sd*shows the highest transcript level with 10 hits. The largest Hippo pathway protein (2764 amino acids) and the smallest one (217 amino acids) are encoded by*Ds* and*Mats*, respectively. Of the 18 Hippo pathway genes, 17 are dispersed on 11 chromosomes and 1 (*Mer*) on an unmapped scaffold. With the exception of *Fat*, the other 17 Hippo pathway genes have accession numbers in NCBI (Table [1](#T1){ref-type="table"}).

The 18 Hippo pathway genes were also searched from 16 arthropod genomes. Each arthropod contains at least one copy (with occasionally gene duplication) of each of the 18 genes, indicating that the *Drosophila* Hippo pathway is evolutionarily conserved in Arthropoda. We selected Yorkie, which is the most critical substrate and downstream effector of the Hippo pathway, to perform a multiple sequence alignment (Table [S2](#SM1){ref-type="supplementary-material"}). The comparison analysis reveals that the Yorkie proteins among five lepidopteran species share the highest identity (73-89%) and that the identity of any two arthropod Yorkie proteins is greater than 34%. A previous phylogenetic analysis shows that arthropod Yorkie proteins form a separate clade among all the animal Yorkie orthologs [@B39]. We then constructed a phylogenetic tree on the basis of the two WW domains of Yorkie proteins from the 16 arthropods (Fig. [2](#F2){ref-type="fig"}), including the five lepidopteran insects for more informative comparison. Importantly, the nodes within the lepidopteran clade present a strong bootstrap support, and the phylogenetic tree shows a clear separation between Insecta and non-Insecta[@B50].

Expression of the Hippo pathway genes is enriched in mitotic tissues
--------------------------------------------------------------------

To understand the physiological function of the Hippo pathway in *Bombyx*, we initially surveyed the temporal and spatial expression patterns of all 18 Hippo pathway genes by microarray analysis. All of the 18 genes have corresponding probes on the oligonucleotide chip [@B47]. We investigated the tissue distribution of the 18 genes on L5-3 using the microarray data of tissue-specific expression [@B47]. The expression of 7 genes (including *Yorkie*) can be detected in at least one of the selected tissues, including testis, ovary, head, integument, Malpighian tubules, fat body, hemocytes, anterior and middle silk glands, and PSG (Fig. [S2](#SM1){ref-type="supplementary-material"}). Significantly, most genes were highly expressed in the gonad (ovary and testis) and the head compared to other tissues.

All 18 genes were also analyzed by qPCR using total RNA isolated from 9 tissues, including fat body, midgut, ovary, wing disc, trachea, Malpighian tubules, hemocyte, prothoracic gland, and silk gland on L5-2. Except *Sd* and *Fat*, the other 16 genes were abundantly expressed in the gonad. *Fat* and *Ex* were highly expressed in the wing disc. *Sd* expression was high in the prothoracic glands (Fig. [3](#F3){ref-type="fig"}). The tissue distribution patterns of *Scrib*, *Dlg*, and *Lgl* were previously reported by Qi et al [@B51]. In consistent with the microarray data, qRCR analysis revealed that gene expression of the Hippo pathway components is particularly enriched in several mitotic tissues, including the gonad and wing disc on L5-2.

Developmental profiles of the Hippo pathway genes are generally similar within each organ but vary greatly in different tissues
-------------------------------------------------------------------------------------------------------------------------------

We initially investigated the temporal expression patterns of 18 Hippo pathway genes from L5-4 to the adult stage by using the microarray data of developmental changes of mRNA [@B47]. The expression of 11 of the 18 genes (including *Yorkie*) was detected (Fig. [S3](#SM1){ref-type="supplementary-material"}). With the exception of *Par3* and *Fat*, which were only detected in male pupae, the expression of the other 9 genes gradually rises from the larval stage to the pupal stage to the adult stage.

To understand the detailed developmental profiles of the 18 genes during*Bombyx*larval-pupal metamorphosis, we performed qPCR analysis using total RNA isolated from the ovary, wing disc, and PSG dissected from 4L-3 to day 2 of the prepupal stage (PP2). In the ovary, with the exception of *Sd*, *Fat*, *Par3*, and*Scrib*, the expression levels of the other 14 genes were higher in the fourth instar than in the fifth instar, and the expression levels of 11 of the 18 genes (*Hippo*, *Warts*, *Mats*, *Yorkie*, *Crb*, *Mer*, *Kbira*, *Dlg*, *Lgl*, *Par3*, and *Par6*) increased on PP2 (Fig. [4](#F4){ref-type="fig"}). In the wing disc, the expression levels of all 18 genes were low on 4L-3 and relatively high from 4L-4 to PP1; with the exception of *Yorkie*, the expression levels of the other 17 genes decreased on PP2 (Fig. [S4](#SM1){ref-type="supplementary-material"}). In the PSG, the expression levels of 9 of the 18 genes (*Hippo*, *Mats*, *Sd*, *Crb*, *Ex*, *Mer*, *Scrib*, *Par6*, and *aPKC*) were low from 4L-3 to PP1; the expression levels of 6 of the 18 genes (*Sav*, *Ds*, *Fat*, *Kibra*, *Dlg*, and *Lgl*) gradually decreased from 4L-3 to PP1, while the expression levels of *Warts*, *Yorkie*, and *Par3* were quite stable during this period. Apart from *Yorkie*, the expression levels of the other 17 genes significantly increased on PP2 (Fig. [5](#F5){ref-type="fig"}). Collectively, the developmental profiles of the 18 Hippo pathway genes were quite similar (with the exception of *Yorkie*) within each organ but varied greatly in different tissues, and all 18 Hippo pathway genes show nearly opposing expression patterns in the wing disc and the PSG on PP2.

*Yorkie* RNAi delays metamorphosis and ovary maturation
-------------------------------------------------------

In *Drosophila*, *Yorkie* mutants display reduced organ growth [@B18]. Thus, we investigated whether *Yorkie* is important for *Bombyx* development using RNAi to suppress *Yorkie* expression (*Yorkie* RNAi) at IW. Interestingly, the wandering behavior was apparently delayed 12 h after *Yorkie* RNAi, compared with the E*GFP* RNAi control animals (Figs. [6](#F6){ref-type="fig"}A and 6A\'). Moreover, all of the *Yorkie* RNAi animals remained at the pupal stages 240 h after RNAi treatment, while all of the control animals had already emerged as adults. The delay of adult emergence in the *Yorkie* RNAi animals was about 12 h (Fig. [6](#F6){ref-type="fig"}B). Notably, 24 h after *Yorkie* RNAi, *Yorkie* expression in the ovary decreased by approximately 90% compared with the control levels; moreover, six Yorkie target genes, including *cycE*, *IAP*, *Ex*, *Mer*, *Hth*, and *Sd*, were significantly downregulated by *Yorkie* RNAi (Fig. [6](#F6){ref-type="fig"}C). Importantly, the *Yorkie* RNAi females laid fewer eggs than the control females (Fig. [6](#F6){ref-type="fig"}D and D\'). In addition, the efficiency of *Yorkie* RNAi in the wing disc was moderate, and *Yorkie* RNAi only slightly decreased its organ size (Figs. [S5](#SM1){ref-type="supplementary-material"}A and S5A\'). The RNAi experiment indicates that Yorkie is required for timely metamorphosis and ovary maturation in *Bombyx*.

*Yorkie^CA^* overexpression accelerates pupation and PSG organ size
-------------------------------------------------------------------

In *Drosophila*, *Yorkie* overexpression induces organ overgrowth [@B18]. To complement the *Yorkie* RNAi experiments, we conducted *V5-Yorkie^CA^* overexpression on L5-2 and observed the effects on *Bombyx* metamorphic development. The wandering behavior was apparently accelerated 120 h after *V5-Yorkie^CA^* overexpression, compared with the*RFP* overexpression control animals (Figs. [7](#F7){ref-type="fig"}A and 7A\'). Interestingly, PSG size was increased approximately 20% by *V5-Yorkie^CA^* overexpression (Fig. [7](#F7){ref-type="fig"}B). *V5-Yorkie^CA^* expression in the ovary increased by 6-fold; meanwhile, six Yorkie target genes were upregulated 3-10-fold by *Yorkie* overexpression (Fig. [7](#F7){ref-type="fig"}C). In addition, the efficiency of *V5-Yorkie^CA^* overexpression in the wing disc was moderate, and *Yorkie* overexpression only slightly increased its organ size (Figs. [S5](#SM1){ref-type="supplementary-material"}B and S5B\'). The overexpression experiment shows that Yorkie facilitates metamorphosis and promotes PSG growth in *Bombyx*.

In preliminary experiments, we found that compared to *RFP* overexpression, *V5-Yorkie*overexpression had very weak stimulatory effects on metamorphosis and PSG growth. As detected by Western blotting in the PSG using the V5 antibody, *V5-Yorkie^CA^*overexpression yielded approximately 5-fold higher protein level than *V5-Yorkie*overexpression (Fig. [7](#F7){ref-type="fig"}D). As monitored by immunohistochemistry using the V5 antibody, the overexpressed *V5-Yorkie^CA^*mainly localized in the nuclei of the fat body cells, while the overexpressed *V5-Yorkie* localized in both nuclei and cytoplasm of the fat body cells (Fig. [7](#F7){ref-type="fig"}E). The more abundant protein level and the nuclear localization of the overexpressed *V5-Yorkie^CA^* are likely responsible for its better stimulatory effects on metamorphosis and PSG growth compared to the overexpressed*V5-Yorkie*.

Discussion
==========

As revealed by microarrays and qPCR, the tissue distribution and developmental profiles of the Hippo pathway genes suggest that the Hippo pathway regulates *Bombyx* organ growth in a context-specific manner. Expression of the Hippo pathway genes on L5-3 or L5-2 is particularly enriched in several mitotic tissues, including the gonad and wing disc (Figs. [S2](#SM1){ref-type="supplementary-material"} and 3). It is likely that the growth of mitotic tissues is restricted by the Hippo pathway at this period. In consistent with this hypothesis, during the larval stages, the mitotic tissues do not grow as dramatically as other larval tissues, such as the silk gland and the fat body that undergo rapid endocycles. During the larval stages, expression levels of the Hippo pathway genes are generally higher at the fourth instar than those at the fifth instar (Figs. [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}, and Fig. [S4](#SM1){ref-type="supplementary-material"}), in agreement with a dramatic body growth at the fifth instar. Moreover, as revealed by microarray analysis, expression levels of the Hippo pathway genes gradually increase from the larval stage through the pupal stage to the adult stage (Fig. [S3](#SM1){ref-type="supplementary-material"}), agreeing that the obsolete larval tissues undergo massive programmed cell death and histolysis during metamorphosis [@B52]. It is possible that the growth of larval tissues is tightly limited and their death is promoted by the Hippo pathway during the non-feeding pupal and adult stages. Interestingly, some Hippo pathway genes are expressed in males but not in females during the pupal stages, implying that pupal development is more restricted by the Hippo pathway in males than in females.

Pronouncedly, the developmental profiles of Hippo pathway genes are generally similar to each other (with the exception of *Yorkie*) within each tissue, but vary greatly in different tissues, including the ovary, wing disc, and PSG. It is likely that the Hippo pathway genes coordinate and control the growth of each organ, but how the pathway regulates this growth might be different in distinct organs. For example, the expression patterns of 18 Hippo pathway genes on PP2 are opposite between the wing disc and PSG (Fig. [5](#F5){ref-type="fig"} and Fig. [S4](#SM1){ref-type="supplementary-material"}). On PP2, the wing disc undergoes dramatic growth [@B53], while the PSG stops cell proliferation and begins programmed cell death with decreased expression of *cycE* and *IAP* [@B54]-[@B57]. Surprisingly, expression of all genes in the Hippo kinase cassette and upstream inputs is low in the wing disc on PP2, but expression of *Yorkie*remains high (Fig. [S4](#SM1){ref-type="supplementary-material"}), suggesting that Yorkie might promote its dramatic growth at this developmental stage. In contrast, expression of all genes in the Hippo kinase cassette and upstream inputs sharply increases in the PSG on PP2, but expression of *Yorkie*decreases (Fig. [5](#F5){ref-type="fig"}), implying that a low Yorkie activity might allow programmed cell death and histolysis to occur in the PSG at this developmental stage. Together, the nearly opposing expression patterns of the Hippo pathway genes between the wing disc and the PSG on PP2 raise the possibility that the Hippo pathway might differently regulate growth of distinct tissues at particular developmental stages.

To understand if physiological function of the Hippo pathway is conserved in *Bombyx*, we performed both loss- and gain-of-function studies of *Yorkie*. It is necessary to note that *Yorkie* RNAi at IW did not cause lethal phenotypes. One reason could be the high expression levels of genes in the Hippo kinase cassette and upstream inputs during the pupal stages (Fig. [S3](#SM1){ref-type="supplementary-material"}) and these genes might have been lowered Yorkie activity during metamorphosis. Meanwhile, although the efficiency of *Yorkie* RNAi was high in the ovary, it was moderate in the wing disc and fat body but extremely low in the PSG (Fig. [6](#F6){ref-type="fig"}, Figs. [S5](#SM1){ref-type="supplementary-material"}, S6). The strongest phenotypes caused by *Yorkie* RNAi or *Yorkie* overexpression are changes in metamorphosis. To our understanding, this is the first time to report that Yorkie facilitates metamorphosis in insects. In accordance with the 20E signaling that determines *Bombyx* metamorphosis [@B53], [@B58]-[@B60], Yorkie promotes timely metamorphosis (Figs. [6](#F6){ref-type="fig"}A-6B, 7A, and 7A\'). Compared with the 20E signaling that causes programmed cell death [@B53], [@B60]-[@B62], Yorkie promotes growth of organs, including the ovary, wing disc, and PSG (Figs. [6](#F6){ref-type="fig"}D, 6D\', 7B, and Fig. [S5](#SM1){ref-type="supplementary-material"}). Using the newly developed CRISPR/Cas9-mediated gene knockout method [@B63] and the GAL4/UAS system [@B56], one might understand how Yorkie regulates organ growth and metamorphosis at the embryonic and early larval stages in *Bombyx*.

During thousands of years of artificial selection, the body size of the domesticated silkworm has been improved; moreover, the organ size of the silk gland has been even more significantly improved. During the fifth larval instar, the silk gland grows dramatically and produces a great amount of fibroin. In terms of protein synthesis, the silk gland is one of the most efficient organs in animals [@B42]. Using the GAL4/UAS system, we have previously demonstrated that Ras signaling, together with insulin-like peptides and nutrients, plays a critical role in the regulation of silk gland growth and silk yield [@B54], [@B56], [@B57]. Considering that baculovirus-mediated *Yorkie^CA^* overexpression accelerates PSG growth (Fig. [7](#F7){ref-type="fig"}), we assume that *Yorkie^CA^* overexpression in the PSG should have similar stimulatory effects on PSG growth to *Ras1^CA^* overexpression. In order to improve silk yield more efficiently, we are considering simultaneous overexpression of *Yorkie^CA^* and *Ras1^CA^* in the PSG. Combining the powerful tools of omics, genetics, and bioinformatics, we have sought to understand how the genetic signaling networks, including 20E signaling, Ras signaling and the Hippo pathway, coordinately regulate the size of the silk gland and the whole body during silkworm domestication.
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![**Significant domains of 18 Hippo pathway genes in *Bombyx*.**The program Pfam was used for domain identification. Please see the details of domain analysis in the text. \* The *Fat* sequence is likely incomplete in the *Bombyx* genome.](ijbsv12p0917g001){#F1}

![**The phylogenetic tree of Yorkie in Arthropoda.**At least one representative genome was selected for most orders of sequenced arthropod species. In total, 16 arthropods were used, including Arachnida (2 species), Myriapoda, Crustacea, and Insecta (12 species, including five lepidopteran species). The protein sequence of *Drosophila* Yorkie was used to search putative orthologs across the whole genomes of the 16 arthropods by reciprocal BLASTP. Multiple alignments of the two WW domains of Yorkie proteins were then performed using MUSCLE, and the conserved blocks of these alignments were extracted using Gblocks. The phylogeny was calculated using PhyML with the JTT model for 100 replicates.](ijbsv12p0917g002){#F2}

![**Tissue distribution patterns of Hippo pathway genes on day 2 of the fifth larval instar.**OV (ovaries); WD (Wing disc); PG (Prothoracic gland); FB (Fat body); TR (Trachea); MT (Malpighian tubule); HA (Hemocytes); SG (Silk gland); MG (Midgut). *Rp49* is used as an internal control. Relative mRNA levels are indicated as the ratios of mRNA levels between the target gene and *Rp49*. Error bars represent the SDs of three independent replicates in this and all subsequent figures. In each replicate, ten animals were used, and triplicate qPCR analyses were conducted.](ijbsv12p0917g003){#F3}

![**Developmental expression profiles of 18 Hippo pathway genes in the ovary from day 3 of the fourth larval instar to day 2 of the prepupal stage.**4L-3 and 4L-4, day 3 and 4 of the fourth larval instar; 4M, the 4th molting; 5L-1 to 5L-7, day 1 to 7 of the fifth larval instar; W, the wandering stage; PP1 and PP2, day 1 and 2 of the prepupal stage.](ijbsv12p0917g004){#F4}

![**Developmental expression profiles of 18 Hippo pathway genes in the posterior silk gland from day 3 of the fourth larval instar to day 2 of the prepupal stage.**4L-3 and 4L-4, day 3 and 4 of the fourth larval instar; 4M, the 4th molting; 5L-1 to 5L-7, day 1 to 7 of the fifth larval instar; W, the wandering stage; PP1 and PP2, day 1 and 2 of the prepupal stage.](ijbsv12p0917g005){#F5}

![***Yorkie* RNAi delays metamorphosis and ovary maturation.**(A and A\') Compared to the E*GFP*RNAi control silkworms, the *Yorkie* RNAi silkworms showed delayed larval-pupal metamorphosis at 24 h after dsRNA treatment. The chart (A\') shows the quantification of silkworms in (A): at the feeding stage or at the initiation of the wandering stage. (B) Compared to the E*GFP* RNAi control silkworms, the *Yorkie* RNAi silkworms showed delayed emergence at 240 h after dsRNA treatment. (C) A comparison of the mRNA levels of the *Yorkie*target genes in the ovary 24 h after dsRNA treatment. (D and D\') Compared to the E*GFP* RNAi control silkworms, the *Yorkie* RNAi silkworm moths showed reduced egg numbers. The chart (D\') shows the quantification of silkworm egg numbers in (D).](ijbsv12p0917g006){#F6}

![***Yorkie^CA^* overexpression accelerates pupation and PSG size.**(A and A\') Compared to the *RFP* overexpression (*RFP* oe) control silkworms, the *Yorkie^CA^* overexpression (*Yorkie^CA^* oe) silkworms showed accelerated larval-pupal metamorphosis at 120 h after baculovirus infection. The chart (A\') shows the quantification of silkworms in (A): at the initiation of the wandering stage or at the wandering and spinning stages. (B) Compared to the *RFP*-overexpressed control silkworms, the *Yorkie^CA^*-overexpression silkworms showed size increases of the posterior silk gland (PSG) at 120 h after baculovirus infection. (C) A comparison of mRNA levels of the *Yorkie* target genes in the posterior silk gland at 120 h after baculovirus infection. (D) Western blotting analysis of the protein levels of overexpressed*V5-Yorkie^CA^* and *V5-Yorkie* in the posterior silk gland at 120 h after baculovirus infection. The V5 antibody detects the overexpressed *V5-Yorkie^CA^* and *V5-Yorkie*at MW \~75 kDa. (E) Immmunohistochemistry analysis of the protein levels of overexpressed *V5-Yorkie^CA^* and *V5-Yorkie* in the fat body at 120 h after baculovirus infection. As denoted by the yellow and red arrows, respectively, the overexpressed *V5-Yorkie^CA^* always localized in the nuclei of the fat body cells, while the overexpressed *V5-Yorkie* localized in both nuclei and cytoplasm of the fat body cells.](ijbsv12p0917g007){#F7}

###### 

Summary of the 18 Hippo pathway genes in the *Bombyx* genome.

  NO.   gene       SilkDB ID       Chr.   Scaffold    Position              EST   Probe     Size (AA)   NCBI ID
  ----- ---------- --------------- ------ ----------- --------------------- ----- --------- ----------- ----------------
  1     *Hippo*    BGIBMGA013478   5      nscaf3075   (+)1302878..1290675   0     sw08605   492         NP_001116818.1
  2     *Sav*      BGIBMGA004937   25     nscaf2822   (-)912627..918022     0     sw11181   402         XP_004924516.1
  3     *Warts*    BGIBMGA006330   6      nscaf2852   (+)1986876..1992247   1     sw05368   1025        XP_004923559.1
  4     *Mats*     BGIBMGA013463   6      nscaf3074   (+)146991..151388     0     sw05526   217         XP_004926597.1
  5     *Yorkie*   BGIBMGA003682   5      nscaf2674   (+)4049793..4052521   2     sw03123   437         NP_001116819.1
  6     *Sd*       BGIBMGA001129   13     nscaf1898   (+)4585777..4618439   10    sw14392   397         XP_004928021.1
  7     *Ds*       BGIBMGA010453   12     nscaf2993   (-)1494834..1480580   0     sw11749   2764        XP_004929431.1
  8     *Fat*      BGIBMGA010597   12     nscaf2995   (+)253973..259252     0     sw21999   1407        NO
  9     *Crb*      BGIBMGA007609   15     nscaf2888   (-)9505337..9522337   0     sw11252   1294        XP_004928825.1
  10    *Ex*       BGIBMGA010558   12     nscaf2993   (+)6011036..6015638   5     sw03959   1268        XP_004929583.1
  11    *Mer*      BGIBMGA014502   UN     nscaf749    (-)6487..18440        0     sw11071   567         XP_004933720.1
  12    *Kibra*    BGIBMGA009269   14     nscaf2943   (+)1377742..1396051   2     sw05915   1162        XP_004922701.1
  13    *Scrib*    BGIBMGA005373   8      nscaf2828   (-)1127705..1141772   1     sw18238   729         XP_004932102.1
  14    *Dlg*      BGIBMGA010382   12     nscaf2993   (-)6758200..6776168   0     sw19956   884         XP_004929498.1
  15    *Lgl*      BGIBMGA005570   17     nscaf2829   (-)1712186..1720814   3     sw12635   1105        XP_004921966.1
  16    *Par3*     BGIBMGA006557   10     nscaf2855   (+)6535850..6549347   0     sw11025   942         XP_004930528.1
  17    *Par6*     BGIBMGA004440   20     nscaf2795   (+)718639..722191     1     sw09724   319         XP_004922525.1
  18    *aPKC*     BGIBMGA014132   8      nscaf463    (+)1220257..1230024   0     sw05322   669         NP_001036978.1
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